Ovulation Induction Techniques in Polycystic Ovary Syndrome - Systematic Review
DOI:
https://doi.org/10.12775/QS.2024.37.57739Keywords
Polycystic ovary syndrome, ovulation induction, Stein-Leventhal Syndrome, infertility treatment, anovulationAbstract
Introduction & Purpose of Research: Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age. Given the high prevalence of PCOS and its impact on infertility, this research explores strategies to stimulate ovulation and improve pregnancy outcomes. To address this issue comprehensively, we specifically selected six main treatment methods: lifestyle changes, clomiphene citrate, antidiabetic drugs, gonadotropin analogues, aromatase inhibitors, and surgical approaches. Our aim was to review various studies, including meta-analyses and comparisons of methods from published texts, to gain valuable insights into the topic.
References
1. Ovulation induction techniques in women with polycystic ovary syndrome
Andreas A Vyrides, Essam El Mahdi, Konstantinos Giannakou
Front Med (Lausanne) 2022 Aug 12:9:982230. doi: 10.3389/fmed.2022.982230. eCollection 2022. PMID: 36035398 PMCID: PMC9411864 DOI: 10.3389/fmed.2022.982230
2. The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
Sylwia Bednarska, Agnieszka Siejka
Advances in Clinical and Experimental Medicine, ISSN 1899-5276 (print), ISSN 2451-2680 (online) DOI 10.17219/acem/59380 Adv Clin Exp Med 2017 Mar-Apr;26(2):359-367. doi: 10.17219/acem/59380.
3. Polycystic ovary syndrome in Latin American populations: What is known and what remains unresolved.
Abruzzese GA, Velazquez ME, Cerrone GE, Motta AB.
J Steroid Biochem Mol Biol. 2023 Jan;225:106195. doi: 10.1016/j.jsbmb.2022.106195. Epub 2022 Sep 29. PMID: 36183993 Review
4.Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Hosna Mohammad Sadeghi, Ida Adeli, Daniela Calina, Anca Oana Docea,Taraneh Mousavi, Marzieh Daniali, Shekoufeh Nikfar, Aristidis Tsatsakis and Mohammad Abdollahi
Int. J. Mol. Sci. 2022, 23(2), 583; https://doi.org/10.3390/ijms23020583
5.Ovulation induction in polycystic ovarian syndrome -basics for gynecologist
Punita Yadav,
International Journal of Reproduction, Contraception, Obstetrics and GynecologyYadav P. Int J Reprod Contracept Obstet Gynecol. 2021Mar;10(3):1236-1240
6. Doppler for prediction of adverse perinatal outcome in preeclampsia in a low resource setting. Agrawal S, Das V, Agarwal A, Pandey A.Fetal
Int J Reprod Contracept Obstet Gynecol 2021;10:1236-40.
7. PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome
Paolo Giovanni Artini, Maria Elena Rosa Obino, Claudia Sergiampietri, Sara Pinelli, Francesca Papini, Elena Casarosa, Vito Cela
PMID: 30058861 DOI: 10.1080/17446651.2018.1431122 Expert Rev Endocrinol Metab 2018 Mar;13(2):87-98. doi: 10.1080/17446651.2018.1431122. Epub 2018 Jan 29.
8. Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Yujie Shang, Huifang Zhou, Ruohan He, Wentian Lu
PMID: 34790167 PMCID: PMC8591222 DOI: 10.3389/fendo.2021.735954 Front Endocrinol (Lausanne) 2021 Nov 1:12:735954. doi: 10.3389/fendo.2021.735954. eCollection 2021.
9. Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity
Stephanie Cowan, Siew Lim, Chelsea Alycia, Stephanie Pirotta, Rebecca Thomson, Melanie Gibson-Helm, Rebecca Blackmore, Negar Naderpoor, Christie Bennett, Carolyn Ee, Vibhuti Rao, Aya Mousa, Simon Alesi, Lisa Moran
PMID: 36647089 PMCID: PMC9841505 DOI: 10.1186/s12902-022-01208-y Review BMC Endocr Disord 2023 Jan 16;23(1):14. doi: 10.1186/s12902-022-01208-y.
10. Effectiveness of Lifestyle Modification in Polycystic Ovary Syndrome Patients with Obesity: A Systematic Review and Meta-Analysis
Chan-Hee Kim, Seon-Heui Lee
PMID: 35207595 PMCID: PMC8876590 DOI: 10.3390/life12020308 Life (Basel) 2022 Feb 18;12(2):308. doi: 10.3390/life12020308.
11. Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS)
Shannon Herbert, Kathleen Woolf
PMID: 38140328 PMCID: PMC10745999 DOI: 10.3390/nu15245069 Nutrients 2023 Dec 11;15(24):5069. doi: 10.3390/nu15245069.
12.Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment
Akihisa Takasaki, Isao Tamura, Maki Okada-Hayashi, Takeshi Orita, Manabu Tanabe, Shoko Maruyama, Katsunori Shimamura, Hitoshi Morioka
PMID: 30377399 PMCID: PMC6194245 DOI: 10.1002/rmb2.12219 Reprod Med Biol 2018 Jul 6;17(4):454-458. doi: 10.1002/rmb2.12219. eCollection 2018 Oct.
13.Identification of predictors of the ovarian response to clomiphene citrate in infertile women with polycystic ovary syndrome: a prospective cohort study
Hexia Xia, Xiaoli Sun, Haiyun Guan, Ruixiu Zhang, Wei Zhang
PMID: 33866836 PMCID: PMC8753794 DOI: 10.1177/03000605211000569 J Int Med Res 2021 Apr;49(4):3000605211000569. doi: 10.1177/03000605211000569.
14.Novel clomiphene "stair-step" protocol reduces time to ovulation in women with polycystic ovarian syndrome
Bradley S Hurst, Jennifer M Hickman, Michelle L Matthews, Rebecca S Usadi, Paul B Marshburn
PMID: 19114272 DOI: 10.1016/j.ajog.2008.10.031 Am J Obstet Gynecol 2009 May;200(5):510.e1-4. doi: 10.1016/j.ajog.2008.10.031. Epub 2008 Dec 27.
15.Clomiphene Stair-Step Protocol for Women With Polycystic Ovary Syndrome
Tiffanny Jones, Jacqueline R Ho, Marc Gualtieri, Janet Bruno-Gaston, Karine Chung, Richard J Paulson, Kristin A Bendikson
PMID: 29215516 DOI: 10.1097/AOG.0000000000002418 Comparative Study Obstet Gynecol 2018 Jan;131(1):91-95. doi: 10.1097/AOG.0000000000002418.
16.First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis
Rui Wang, Wentao Li, Esmée M Bordewijk, Richard S Legro, Heping Zhang, Xiaoke Wu, Jingshu Gao, Laure Morin-Papunen, Roy Homburg, Tamar E König, Etelka Moll, Sujata Kar, Wei Huang, Neil P Johnson, Saad A Amer, Walter Vegetti, Stefano Palomba, Angela Falbo, Ülkü Özmen, Hakan Nazik, Christopher D Williams, Grasso Federica, Jonathan Lord, Yilmaz Sahin, Siladitya Bhattacharya, Robert J Norman, Madelon van Wely, Ben Willem Mol
PMID: 31647106 DOI: 10.1093/humupd/dmz029 Meta-Analysis Hum Reprod Update 2019 Nov 5;25(6):717-732. doi: 10.1093/humupd/dmz029.
17.Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
Abigail Sharpe, Lara C Morley, Thomas Tang, Robert J Norman, Adam H Balen
PMID: 31845767 PMCID: PMC6915832 DOI: 10.1002/14651858.CD013505 Meta-Analysis Cochrane Database Syst Rev 2019 Dec 17;12(12):CD013505. doi: 10.1002/14651858.CD013505.
18.Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials
S Palomba, A Falbo, G B La Sala
PMID: 23194199 DOI: 10.1111/1471-0528.12070 BJOG 2013 Feb;120(3):267-76. doi: 10.1111/1471-0528.12070. Epub 2012 Nov 30.
19.The effect of metformin use on pregnancy rates among polycystic ovary syndrome patients undergoing in vitro fertilization: A retrospective-cohort study
Yazed Sulaiman Al-Ruthia, Hazem Al-Mandeel, Hisham AlSanawi, Bander Balkhi, Wael Mansy, Reem AlGasem, Lama AlMutairi
PMCID: PMC5605958 PMID: 28951677 Saudi Pharm J. 2017 Feb 14;25(6):906–910. doi: 10.1016/j.jsps.2017.02.008
20.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Lara C Morley, Thomas Tang, Ephia Yasmin, Robert J Norman, Adam H Balen
PMID: 29183107 PMCID: PMC6486196 DOI: 10.1002/14651858.CD003053.pub6 Cochrane Database Syst Rev 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
21.Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
Leopoldo O Tso, Michael F Costello, Luiz Eduardo T Albuquerque, Regis B Andriolo, Cristiane R Macedo
PMID: 33347618 PMCID: PMC8171384 DOI: 10.1002/14651858.CD006105.pub4 Cochrane Database Syst Rev 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4.
22.The use of metformin in women with polycystic ovary syndrome: an updated review
Adriana Leal Griz Notaro, Filipe Tenorio Lira Neto
PMID: 35156149 PMCID: PMC8995234 DOI: 10.1007/s10815-022-02429-9 J Assist Reprod Genet 2022 Mar;39(3):573-579. doi: 10.1007/s10815-022-02429-9. Epub 2022 Feb 14.
23.Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome
Sebastian Franik, Quang-Khoi Le, Jan Am Kremer, Ludwig Kiesel, Cindy Farquhar
PMID: 36165742 PMCID: PMC9514207 DOI: 10.1002/14651858.CD010287.pub4 Cochrane Database Syst Rev 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4.
24.Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis
Alexandra P Tsiami, Dimitrios G Goulis, Alexandros I Sotiriadis, Efstratios M Kolibianakis
PMID: 34033068 DOI: 10.1007/s42000-021-00289-z Hormones (Athens) 2021 Sep;20(3):449-461. doi: 10.1007/s42000-021-00289-z. Epub 2021 May 25.
25.Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials
Shifu Hu, Qiong Yu, Yingying Wang, Mei Wang, Wei Xia, Changhong Zhu
PMID: 29392438 DOI: 10.1007/s00404-018-4688-6 Arch Gynecol Obstet 2018 May;297(5):1081-1088. doi: 10.1007/s00404-018-4688-6. Epub 2018 Feb 1.
26.Letrozole versus laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
Qiong Yu, Shifu Hu, Yingying Wang, Guiping Cheng, Wei Xia, Changhong Zhu
PMID: 30728032 PMCID: PMC6366034 DOI: 10.1186/s12958-019-0461-3 Reprod Biol Endocrinol 2019 Feb 6;17(1):17. doi: 10.1186/s12958-019-0461-3.
27. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome
Nienke S Weiss, Elena Kostova, Marleen Nahuis, Ben Willem J Mol, Fulco van der Veen, Madelon van Wely
PMID: 30648738 PMCID: PMC6353048 DOI: 10.1002/14651858.CD010290.pub3 Cochrane Database Syst Rev 2019 Jan 16;1(1):CD010290. doi: 10.1002/14651858.CD010290.pub3.
28.Low-dose gonadotropin induction of ovulation in anovulatory women: still needed in the age of IVF
Davinia M White, Kate Hardy, Suzannah Lovelock, Stephen Franks
PMID: 29459401 DOI: 10.1530/REP-17-0697 Reproduction 2018 Jul;156(1):F1-F10. doi: 10.1530/REP-17-0697. Epub 2018 Feb 19
29.Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk
Rui Gao, Xin Liao, Wanrong Huang, Rujun Zeng, Lang Qin, Peng Bai
PMID: 35757417 PMCID: PMC9232123 DOI: 10.3389/fendo.2022.905263 Front Endocrinol (Lausanne) 2022 Jun 10:13:905263. doi: 10.3389/fendo.2022.905263. eCollection 2022.
30.Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial
Mahmoud Thabet, Mohamed Sayed Abdelhafez, Maged Ragheb Elshamy, Ibrahim A Albahlol, Emad Fayala, Alaa Wageeh, Ahmed Abdelhamid El-Zayadi, Nagwan Ahmed Bahgat, Shereen M Mohammed, Alhussein Ahmed Mohamed, Mahmoud Mohamed Awad, Ahmed El-Menayyer, Mohamed El-Sherbiny, Dalia Mahmoud Abdelmonem Elsherbini, Rayan G Albarakati, Ahmed Baker A Alshaikh, Fawaz E Edris, Nayla Jamal Bushaqer, Youstina Georges Makarious Salama, Mahmoud Mohamed Abdel-Razik
PMID: 39202581 PMCID: PMC11356540 DOI: 10.3390/medicina60081300 Medicina (Kaunas) 2024 Aug 12;60(8):1300. doi: 10.3390/medicina60081300.
31.Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
Esmée M Bordewijk, Ka Ying Bonnie Ng, Lidija Rakic, Ben Willem J Mol, Julie Brown, Tineke J Crawford, Madelon van Wely
PMID: 32048270 PMCID: PMC7013239 DOI: 10.1002/14651858.CD001122.pub5 Cochrane Database Syst Rev 2020 Feb 11;2(2):CD001122. doi: 10.1002/14651858.CD001122.pub5.
32.The effect of laparoscopic ovarian drilling on pregnancy outcomes in polycystic ovary syndrome women with more than 2 in-vitro fertilization cycle failures: A pilot RCT
Ashraf Moini, Tayebeh Esfidani, Arezoo Arabipoor, Reihaneh Hosseini, Shima Mohiti, Sakineh Noor Mohammadi
PMID: 38292507 PMCID: PMC10823117 DOI: 10.18502/ijrm.v21i11.14653 Int J Reprod Biomed 2023 Dec 19;21(11):901-908. doi: 10.18502/ijrm.v21i11.14653. eCollection 2023 Nov.
33. Laparoscopic ovarian drilling before IVF/ICSI in polycystic ovarian syndrome patients with high antimullarian hormone
Mohamed Sayed Abdelhafez, Maher Shams, Mahmoud Mohamed Abdel-Razik, Alaa Wageh
PMID: 35063718 DOI: 10.1016/j.jogoh.2022.102324 J Gynecol Obstet Hum Reprod 2022 Mar;51(3):102324. doi: 10.1016/j.jogoh.2022.102324. Epub 2022 Jan 19.
34. Metformin With or Without Clomiphene Citrate Versus Laparoscopic Ovarian Drilling With or Without Clomiphene Citrate to Treat Patients With Clomiphene Citrate-Resistant Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Ming-Li Sun , Wen-Pei Bai, Qing-Kun Song, Hui-Ying Wang, Guo-Lan Gao, Liang Zheng, Xing-He Wang
PMID: 35814214 PMCID: PMC9256960 DOI: 10.3389/fphar.2022.576458 Front Pharmacol 2022 Jun 22:13:576458. doi: 10.3389/fphar.2022.576458. eCollection 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Daria Michałka, Natalie Papachristoforou, Natalia Tekiela, Zuzanna Gałuszka , Monika Makar , Tomasz Bartuś , Emilia Bąk, Justyna Głowacka , Aleksandra Kocjan , Radosław Chmiel
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 29
Number of citations: 0
